StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
An uptick in initial public offering (IPO) filings in recent weeks suggests that the market for first-time biotech stocks is finally recovering after three years of sparse activity capped by share prices that had...
PacBio to commence first customer shipments of Revio long-read sequencing systems
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023. As previously announced, the Revio system features...
Engineered E. coli shows promise in cancer immunotherapy
Study title: Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell therapy
Publication: Nature Biotechnology
Dana-Farber Cancer Institute authors: Rizwan Romee, MD, Shaobo Yang, Michal Sheffer, PhD, David Barbie, MD, Catherine Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD
Endpoints: Critical Preclinical Markers in Extracellular Protein Degradation Assays
REGISTER NOW
Broadcast Date: Thursday, October 24, 2024Time: 8:00 am PT, 11:00 am ET, 17:00 CEST
Therapeutics that leverage protein degradation as their primary mechanism of action appear to be a validated new...
Heightened Genetic Disease Risk Linked to Remote Regions in the U.K.
Individuals from isolated parts of the U.K. could have variations in their genetic code that increase their chance of developing certain diseases, according to a new study “Regionally enriched rare deleterious exonic variants in...
Intestinal Organoids Reveal Tuft Cells’ Role in Regeneration
Tuft cells are present throughout the intestinal tract as well as in many organs. Studies in mice have shown that when tuft cells sense the presence of pathogens, they signal to immune cells and...
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
If we want to increase longevity and reverse aging, we need to get serious. Forget myth. There is no fountain of youth. And we need to move beyond practical advice. Healthy habits will accomplish...
Aptadir Therapeutics Pioneers RNA Inhibitors That Target Hypermethylation in Rare Genetic Disorders
Interest in RNA-based therapeutics shows no signs of slowing down anytime soon. One of the newest entrants into the market, Aptadir recently announced its plans to develop RNA therapies for rare cancers and genetic...
New humanized mouse models created to study COVID-19
Scientists at La Jolla Institute for Immunology (LJI) have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19. According to their new study in eBioMedicine,...
Biologics Manufacturing: Maximizing Productivity Using Process Intensification
REGISTER NOW
Panelists:
Nick HutchinsonHead of Market DevelopmentJust – Evotec Biologics
Michael Coolbaugh, PhDAssociate DirectorSanofi
Miriam MongeHead of Market Communication Strategy and Customer AdvocacySartorius
Priyanka GuptaSenior Marketing ExpertBioprocess SolutionsSartorius
Broadcast...